Catalyst Wire Dossier Catalyst Wire Dossier

Intranasal Lacrimal Neurostimulator

· Oculeve, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intranasal Lacrimal Neurostimulator, covering 2017-10-31 to 2017-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator [NA]

See pricing